Press Releases

 Filter by Provider

Revvity, Inc. (NYSE: RVTY), today announced that it will release its second quarter 2025 financial results prior to market open on Monday, July 28, 2025. The Company will host a conference call the same day at 8:00 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.

GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website.

Orange County Business Journal once again recognizes Toshiba America Business Solutions' welcoming and affirming atmosphere by naming the solutions innovator a 2025 Best Place to Work in Orange County, California. Orange County Business Journal also honored Toshiba as a 2024 Best Place to Work.

The SPAC Market Trends & Sentiment Survey, recently conducted by DealFlow Events at The SPAC Conference

Evercore (NYSE: EVR) announced today that Jon Josephs has joined the firm as a senior managing director in the Industrials Investment Banking group, focused on capital goods and large-cap diversified companies, based in New York.

PR N°C3346C

MARKHAM, Ontario, July 07, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second quarter of 2025 after market close on Wednesday, August 6, 2025. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Executive Vice President and Chief Financial Officer, will be held on Thursday, August 7, 2025, at 11:30 a.m. (EDT) to discuss the results.

ARLINGTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that the Company will host a webcast event with Key Opinion Leaders (KOLs) to discuss the potential of KPI-012 for the treatment of persistent corneal epithelial defect (PCED). The event will take place on Wednesday, July 16, 2025, at 4:00 p.m. ET.

Latest In a Series of Asset-Backed Financings for the Lessor as It Increases Fleet Size, Borrowing Capability to Fund Additional Growth

SINGAPORE, July 07, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited production and mining operation updates for June 2025.

   

PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed patient enrollment in its Phase 3 UTOPIA clinical trial of UGN-103 (mitomycin) for intravesical solution, a next-generation formulation in development for the treatment of recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Durham/Chapel Hill Revealed as Second Location with $10+Million Investment Commitment

SAN FRANCISCO, CA / ACCESS Newswire / July 7, 2025 / In This Article, You'll Discover:

Large Implications for Cognitive Aging and Dementia

FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today that it has received a purchase order from Centre Hospitalier Universitaire (CHU) de Rennes. This is the first purchase order from Universite de Rennes and marks the largest purchase order for the VIVO product line to date.

Former Abbott executive who led the US launch and global expansion of Humira® adds three decades of commercial and clinical leadership expertise

IRVINE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two live case broadcasts, demonstrating the expanding use of the Trilogy system in aortic regurgitation (AR) patients.

After previous success with its BigCommerce B2C site, Graham & Brown launched a B2B site for distribution of products in the UK and across Europe

STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced its Board of Directors has authorized a new share repurchase program to repurchase up to $150 million in common stock through December 31, 2026. This program replaces a previous $150 million share repurchase program authorized in January 2024 which expired on June 30, 2025, and had $65 million remaining under the program.

LIVONIA, Mich., July 07, 2025 (GLOBE NEWSWIRE) -- LIVONIA, Mich. – MedCerts, a Stride, Inc. company and a leader in online career training, is proud to announce a transformative new partnership with Tier One Career and Technical Institute, expanding access to high-demand, industry-recognized certification programs in the healthcare and information technology (IT) sectors. 

DALLAS, July 07, 2025 (GLOBE NEWSWIRE) -- Westwood Holdings Group (WHG), a publicly-traded investment management boutique and wealth management firm, today announced monthly income distributions for Westwood Salient Enhanced Midstream Income ETF (NYSE: MDST) and Westwood Salient Enhanced Energy Income ETF (NASDAQ: WEEI) as shown in the table below. This pair of Westwood Exchange- Traded Funds (ETFs) deliver income from both dividends and options premiums to help provide monthly income distributions for investors. Most recently, both strategies are providing double-digit income to investors.

Celebration, FL, July 07, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced the launch of My Agent Account Version 4.0, a major enhancement to the Company’s proprietary agent platform. The new version, which went live on July 1, 2025, features a fully integrated Transaction Management module that is intended to deliver significant cost savings to the Company by improving efficiency, reducing manual processes, and eliminating reliance on expensive third-party systems.

Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties on net sales

Aaron Miller Named Chairman of APPS, Expected to Retire at End of 2026

SOUTH SAN FRANCISCO, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) seeking accelerated approval for tividenofusp alfa for the treatment of Hunter syndrome (mucopolysaccharidoses type II, or MPS II), a rare and progressive genetic disorder. The FDA granted the BLA Priority Review with a Prescription Drug User Fee Act (PDUFA) target action date of January 5, 2026.

The Nassau Companies of New York announced today that it has commenced a private offering (the “Offering”) of $400 million aggregate principal amount of its senior notes due 2030 (the “2030 Notes”), subject to market and other conditions.

TALLMADGE, OH / ACCESS Newswire / July 7, 2025 / If you've been struggling with stubborn weight that just won't seem to budge-no matter how much you diet or exercise-you're not alone. Many people find it difficult to shed extra pounds due to hidden internal factors that go beyond calorie counting. That's where Sleep Lean comes into the picture.

Mumbai, India--(Newsfile Corp. - July 7, 2025) - Unico Connect, a leading software development agency, has announced new enhancements that...

Mogo Inc. (“Mogo” or the “Company”) (NASDAQ: MOGO; TSX: MOGO), a Canadian financial technology company offering solutions across wealth, lending, and payments, today announced that it repurchased approximately 2% of its currently issued and outstanding shares during the second quarter of 2025 under its previously announced NASDAQ buyback program.

TORONTO, ON / ACCESS Newswire / July 7, 2025 / Electric Metals (USA) Limited ("EML" or the "Company") (TSXV:EML)(OTCQB:EMUSF) which aims to become a leading producer of high-value, high-purity manganese chemical and metal products from North America's highest-grade manganese deposit in Emily, Minnesota serving the electric vehicle, defense, technology, and industrial sectors to strengthen American manufacturing and advance national security objectives, is pleased to announce that Brian Savage, the Company's Chief Executive Officer, has been appointed Corporate Secretary effective immediately.

VANCOUVER, BC / ACCESS Newswire / July 7, 2025 / Amarc Resources Ltd. ("Amarc" or the "Company") (TSXV:AHR)(OTCQB:AXREF) is pleased to announce that Carol Li has joined Amarc and, effective July 19, 2025, will be Chief Financial Officer ("CFO") of the Company. She will be transitioning into the role until that time.

The "Lab-on-a-Chip and Microfluidics World Congress 2025" conference has been added to ResearchAndMarkets.com's offering.

New Cayenne Electric variant will be an addition to the existing combustion engine and hybrid model lineup

Strategic Expansion Anchors HUBC’s Platform at the Intersection of Confidential AI, Cybersecurity, and the Decentralized Economy

The "UK Elevators & Escalators Market - Size & Growth Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.

TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) will release its second quarter 2025 operating and financial results after the market closes on Wednesday August 6, 2025. The Company will host a conference call and webcast to discuss the results on Thursday August 7, 2025, at 9:00 a.m. Eastern Time. Details for the conference call and webcast are included below.

WASHINGTON, July 07, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the release of its 2025 U.S. Online Retail Report which projects e-commerce sales will hit $1.27 trillion in 2025, an 8.5% increase over last year. Despite the positive projection, the report found that online retail market share may be approaching a ceiling by the end of the decade, as consumers look for e-commerce to be increasingly integrated with all their retail experiences.

WAYZATA, MN / ACCESS Newswire / July 7, 2025 / Mill City Ventures III, Ltd. ("Mill City") (NASDAQ:MCVT), a non-bank lender and specialty finance company, announced today it has amended a $2.5 million credit facility by increasing the interest rate from 15% to 24% and extending the maturity date. In addition, the company funded a new $400,000 secured short-term loan bearing a 24% interest rate.

Tradeweb Markets Inc. (Nasdaq: TW), a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, today reported total trading volume for the month of June 2025 of $52.0 trillion (tn)1. Average daily volume (ADV) for the month was $2.4tn, an increase of 25.9 percent (%) year-over-year (YoY). For the second quarter of 2025, total trading volume was a record $165.3tn and ADV was a record $2.6tn, an increase of 32.7% YoY, with preliminary average variable fees per million dollars of volume traded of $2.30 and total preliminary fixed fees for rates, credit, equities and money markets of $93.8 million (mm)2. Excluding the impact of the ICD acquisition, which closed on August 1, 2024, total ADV for the month of June was up 13.0% YoY.

Organon (NYSE: OGN), a global independent healthcare company with a focus on women’s health, today announced that VTAMA® (tapinarof) cream, 1%, was granted a strong recommendation by the American Academy of Dermatology (AAD) in their 2025 focused guideline update for the management of adults with moderate to severe atopic dermatitis (AD). The recommendation underscores VTAMA cream as an effective, steroid-free option for daily disease management, with no label warnings or precautions, no contraindications, and no restrictions on duration of use or percentage of body surface area affected. In AD, the most common adverse reactions (incidence ≥1%) were: upper respiratory tract infection, folliculitis, lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and abdominal pain.

Vince Holding Corp., (NYSE: VNCE) (“VNCE” or the “Company”), a global contemporary retailer, today announced that Brendan Hoffman, Chief Executive Officer, and Yuji Okumura, Chief Financial Officer, will participate in a fireside chat hosted by Eric Beder from Small Cap Consumer Research on Thursday, July 10, 2025 at 12:00 p.m. Eastern Time.

HIGHLIGHTS

CINCINNATI, July 07, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it has acquired a full-service durable medical equipment (“DME”) provider, which is wholly owned by Ballad Health (the “Acquiree”). Ballad Health is a prominent integrated health system comprised of 20 hospitals, post-acute care and behavioral health services, and a large multi-specialty group physician practice. Ballad Health serves 29 counties of the Appalachian Highlands in Northeast Tennessee, Southwest Virginia, Northwest North Carolina and Southeast Kentucky. The Acquiree reported unaudited revenue of $6.6 million for the fiscal year ended June 30, 2025, serving over 12,500 patients annually through four branch locations across East Tennessee and Southwest Virginia.

LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro was initially approved on November 15, 2023, for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). In June 2024, Augtyro obtained an indication for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity and have progressed following treatment or have no satisfactory alternative therapy. The approval was based on results from the TRIDENT-1 clinical trial (NCT03093116), which evaluated Augtyro in adult patients with ROS1-positive locally advanced or metastatic NSCLC and NTRK-positive solid tumors.1  

DANBURY, Conn., July 07, 2025 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq: FCEL) President and CEO Jason Few has issued a statement praising the “One Big Beautiful Bill Act” (OBBBA) for its direct support of the fuel cell industry and its role in strengthening America’s energy infrastructure, data center resilience, and clean manufacturing base.

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company’s leadership position in the clinical research industry, cutting-edge innovation, its efforts in inclusion and sustainability, and as an employer of choice.

MONTRÉAL, July 07, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to provide an update on its second quarter 2025 preliminary deliveries, revenues and cash margin, as well as on its cash and debt positions as at June 30th, 2025. All monetary amounts included in this report are expressed in United States dollars, unless otherwise noted.

SYDNEY, July 07, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for June 2025.